Toxicology study of Hippolytii birch (B. Hippolytii. Sukacz) leaves and flat leaved birch (B.Platyphylla. Sukacz)
- VernacularTitle:Хавтага навчит хус (Betula Platyphylla. Sukacz), ипполитийн хус (Betula Hippolytii. Sukacz) хоёр зүйлийн хусны навчны хорон чанарын судалгааны дүн
- Author:
Munkhbayar N
1
;
Davaasambuu T
2
;
Murata T
3
;
Ariunaa Z
4
;
Tserendulam L
1
;
Selenge E
1
Author Information
1. Mongolian University of Pharmaceutical Sciences
2. Monos Drug Research Institute
3. Tohoku medicinal and Pharmaceutical University of Japan
4. Mongolian Traditional Science Technological Corporation
- Publication Type:Journal Article
- Keywords:
flat leaved birch;
hippolytii birch;
Betula platyphylla. Sukacz;
Betula hippolytii. Sukacz;
acute toxicity
- From:
Mongolian Pharmacy and Pharmacology
2021;18(1):17-23
- CountryMongolia
- Language:Mongolian
-
Abstract:
Abstract:Numerous researches conducted in Russia, Bulgaria, Japan, and China on B.pubescens, B. pendula, B.rezniczenkoana (Litv) Schischk, B.humilis Schrank, B.mandshurica Rgl Nakai found that birch barks and leaves contain antioxidants and they have anti-cancer, anti-fungi, antibac- terial and anti-inflammatory properties, protect liver and promote bile secretion. Flat leaved birch (B.platyphylla Sukacz) cortex contains betulin and lupeol of triterpenoids and it’s leaves contain flavonoid and polyphenol compounds. The amounts of compounds found in the cortex are smaller than leaves. Specifically, the amount of flavonoid in leaves is more contained than the that of cortex and leaf buds. In any pharmacology study of new medicines, determination and evaluation of toxicity is the first priority. According to scientific evidences that birch leaves are considered to have less toxins. Not many studies have been conducted on determining toxicity of birch leaves in Mongolia. Therefore, the purpose of this research is to study the species of birches, hippolytii birch (B.hippolytii. Sukacz) and flat leaved birch (B.platyphylla. Sukacz), that were noted to have medical properties in traditional medications and identify their acute toxicity using dry extract and determine mortality dosage (LD50) on animals.
Research materials and methods:Evaluation of the acute toxicity of birch leaves was conducted in Pharmacology laboratory of Monos group’s Drug Research Institute between June 19, 2020 and August 10. In this research, 150-204 g of WISTAR breed non-linear 44 white rats were used and 20 g of B.Hippolytii’s dry extract and 20 g of B. Platyphylla ‘s dry extract were injected.
The experiments to determine the toxicity of dry extracts of B. hippolytii and B. platyphylla (LD50) were conducted according to Litchfield and Wilcoxon’s method and subcutaneous injects were per formed in the pelvic area of the rats.
Results of determining acute toxicity level:The experiments to determine the acute toxicity level of the birch’s dry extracts followed Litchfield and Wilcoxon’s method with 2-stage. LD50 level was determined from the first stage of the research using G.N.Pirshen’s method and the toxicity level was identified using K.K.Sidorov’s toxicity categorization.
From the acute toxicity research, no-observed-adverse-effect level (NOAEL), animal daily dosage and human daily dosage (experimental) were determined. LD50 2950 mg/kg was determined as a result of acute toxicity research of B.hippolytii and B.platyphilla leaves’ dry extract.
- Full text:MPPJ-2021-18(1)-17-23.docx
